ÀBÀlex Bayés

Àlex Bayés

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Àlex Bayés has a total of 365 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy

    by Juliana Ribeiro-Constante, Alba Tristán-Noguero, Fernando Francisco Martínez Calvo, Salvador Ibañez-Mico, José Luis Peña Segura, José Miguel Ramos-Fernández, María del Carmen Moyano Chicano, Rafael Camino León, Víctor Soto Insuga, Elena González Alguacil, et al.

  • Open Access

    NREM Oscillations Mediate Synaptic Proteome Remodelling to Support Synapse Stabilisation

    by Diego del Castillo-Berges, Ana Cazurro-Gutierrez, Oriana Zerpa-Rios, Amalia Peñuela, Daniel Arco-Alonso, Carla Viñola-Renart, Gisela Espriu-Aguado, Danique Zantinge, Thomas Vaissière, Camilo Rojas, et al.

    Synapses are known to remodel their proteome during sleep. However, the exact mechanisms driving this remodelling and its impact on synaptic function or cognition are not well understood. We combine 24-hour EEG recordings with time-resolved synaptic proteomics in a model of SYNGAP1 -Related Disorders to reveal a mechanism by which slow-waves and spindles, two NREM sleep oscillations, mediate the remodelling of the synaptic proteome. Moreover, we uncover that this remodelling promotes synaptic stabilization, which could support sleep-dependent memory consolidation. In contrast, the increase of slow-waves and decrease of spindles found in Syngap1 +/- mice would activate molecular pathways involved in synaptic weakening instead of stabilization. This is consistent with the proposed roles of slow-waves and spindles in synaptic downscaling and potentiation, respectively. Here, we provide evidence on how NREM oscillations regulate the synaptic proteome and reveal a pathological mechanism that could be of relevance to all neurodevelopmental disorders coursing with sleep disturbances.

  • Open Access

    Genotype-phenotype correlations and putative modifier genes in SYNGAP1 Encephalopathy

    by Selena Aranda, Juliana Ribeiro-Constante, Alba Tristán-Noguero, Nerea Moreno-Ruiz, Concepción Arenas, Fernando Francisco Martínez Calvo, Salvador Ibáñez-Micó, José Luis Peña Segura, José Miguel Ramos-Fernández, María del Carmen Moyano Chicano, et al.


  • Open Access

    Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

    by Rita Reig-Viader, Diego del Castillo-Berges, Albert Burgas-Pau, Daniel Arco-Alonso, Oriana Zerpa-Rios, David Ramos-Vicente, Javier Picañol, Aida Castellanos, David Soto, Nerea Roher, et al.

    Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins.


  • Open Access

    Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

    by Rita Reig-Viader, Diego del Castillo-Berges, Albert Burgas-Pau, Daniel Arco-Alonso, Oriana Zerpa-Rios, David Ramos-Vicente, Javier Picañol, Aida Castellanos, David Soto, Nerea Roher, et al.

    Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognised neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins.


  • Open Access

    Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy

    by Juliana Ribeiro-Constante, Alba Tristán-Noguero, Fernando Francisco Martínez Calvo, Salvador Ibañez-Mico, José Luis Peña Segura, José Miguel Ramos-Fernández, María del Carmen Moyano Chicano, Rafael Camino León, Víctor Soto Insuga, Elena González Alguacil, et al.

    SYNGAP1 haploinsufficiency results in a developmental and epileptic encephalopathy (DEE) causing generalized epilepsies accompanied by a spectrum of neurodevelopmental symptoms. Concerning interictal epileptiform discharges (IEDs) in electroencephalograms (EEG), potential biomarkers have been postulated, including changes in background activity, fixation-off sensitivity (FOS) or eye closure sensitivity (ECS). In this study we clinically evaluate a new cohort of 36 SYNGAP1-DEE individuals. Standardized questionnaires were employed to collect clinical, electroencephalographic and genetic data. We investigated electroencephalographic findings, focusing on the cortical distribution of interictal abnormalities and their changes with age. Among the 36 SYNGAP1-DEE cases 16 presented variants in the SYNGAP1 gene that had never been previously reported. The mean age of diagnosis was 8 years and 8 months, ranging from 2 to 17 years, with 55.9% being male. All subjects had global neurodevelopmental/language delay and behavioral abnormalities; 83.3% had moderate to profound intellectual disability (ID), 91.7% displayed autistic traits, 73% experienced sleep disorders and 86.1% suffered from epileptic seizures, mainly eyelid myoclonia with absences (55.3%). A total of 63 VEEGs were revised, observing a worsening of certain EEG findings with increasing age. A disorganized background was observed in all age ranges, yet this was more common among older cases. The main IEDs were bilateral synchronous and asynchronous posterior discharges, accounting for ≥50% in all age ranges. Generalized alterations with maximum amplitude in the anterior region showed as the second most frequent IED (≥15% in all age ranges) and were also more common with increasing age. Finally, diffuse fast activity was much more prevalent in cases with 6 years or older. To the best of our knowledge, this is the first study to analyze EEG features across different age groups, revealing an increase in interictal abnormalities over infancy and adolescence. Our findings suggest that SYNGAP1 haploinsufficiency has complex effects in human brain development, some of which might unravel at different developmental stages. Furthermore, they highlight the potential of baseline EEG to identify candidate biomarkers and the importance of natural history studies to develop specialized therapies and clinical trials.


  • Open Access

    CHARACTERIZATION OF A NEW HUMAN NEURONAL MODEL FOR SYNGAP1 DISEASE

    by Oriana Zerpa Rios, Christina Au Yeung, Alba Tristan-Noguero, Diego Del Castillo-Berges, Cristian De Quintana-Schmidt, Michael Peitz, Nerea Roher, Oliver Brüstle, Àlex Bayés

  • Open Access

    MOLECULAR ALTERATIONS UNDERLYING SYNAPTIC DYSFUNCTION IN SYNGAP1 HAPLOINSUFFICIENCY

    by Àlex Bayés, Gemma Gou, Amalia Peñuela-Suarez, Diego Del Castillo-Berges, Gavin Rumbaugh

  • Open Access

    IMPAIRED SYNAPTIC DYNAMICS TRIGGERED BY SLEEP/WAKE CYCLE IN SYNGAP+/- MICE.

    by Diego Del Castillo-Berges, Amalia Peñuela-Suarez, Àlex Bayés

  • Open Access

    Endogenous Syngap1 alpha splice forms promote cognitive function and seizure protection

    by Murat Kilinc, Vineet Arora, Thomas K Creson, Camilo Rojas, Aliza A Le, Julie Lauterborn, Brent Wilkinson, Nicolas Hartel, Nicholas Graham, Adrian Reich, et al.

    Loss-of-function variants in SYNGAP1 cause a developmental encephalopathy defined by cognitive impairment, autistic features, and epilepsy. SYNGAP1 splicing leads to expression of distinct functional protein isoforms. Splicing imparts multiple cellular functions of SynGAP proteins through coding of distinct C-terminal motifs. However, it remains unknown how these different splice sequences function in vivo to regulate neuronal function and behavior. Reduced expression of SynGAP-α1/2 C-terminal splice variants in mice caused severe phenotypes, including reduced survival, impaired learning, and reduced seizure latency. In contrast, upregulation of α1/2 expression improved learning and increased seizure latency. Mice expressing α1-specific mutations, which disrupted SynGAP cellular functions without altering protein expression, promoted seizure, disrupted synapse plasticity, and impaired learning. These findings demonstrate that endogenous SynGAP isoforms with α1/2 spliced sequences promote cognitive function and impart seizure protection. Regulation of SynGAP-αexpression or function may be a viable therapeutic strategy to broadly improve cognitive function and mitigate seizure.